Chinese medicine for residual symptoms of COVID-19 recovered patients (long COVID)—A double-blind, randomized, and placebo-controlled clinical trial protocol

INTRODUCTION: Coronavirus disease 2019 (COVID-19) is the current global pandemic of which residual symptoms exhibited by post-acute, rehabilitating patients include fatigue, dyspnoea, and insomnia. Chinese medicine (CM) has been widely used in China to treat different stages of COVID-19. While there...

Descripción completa

Detalles Bibliográficos
Autores principales: Sum, Chi Him, Ching, Jessica Yuet Ling, Song, Tianhe, Cheong, Pui Kuan, Lo, Cho Wing, Lai, Mei Kwan, Chia, Chon Pin, Chan, Kam Leung, Mak, Wing Yan, Leung, Ka Chun, Leung, Sin Bond, Zhang, Hongwei, Lin, Zhixiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846609/
https://www.ncbi.nlm.nih.gov/pubmed/36687403
http://dx.doi.org/10.3389/fmed.2022.990639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846609/
https://www.ncbi.nlm.nih.gov/pubmed/36687403
http://dx.doi.org/10.3389/fmed.2022.990639

Ejemplares similares